Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 24Neoplasms 12Colonic Neoplasms 12Breast Neoplasms 12Prostatic Neoplasms 9Polycythemia Vera 9Venous Thromboembolism 8Multiple Myeloma 8Recurrence 5Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Thrombocythemia, Essential 4Ovarian Neoplasms 4Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Barrett Esophagus 4Precancerous Conditions 3Melanoma 3Esophageal Neoplasms 3Adenomatous Polyps 3Adenoma 3Tobacco Use Disorder 2Thrombosis 2Thromboembolism 2Smoking Cessation 2Sarcoma 2Primary Myelofibrosis 2Neoplastic Cells, Circulating 2Neoplasms by Site 2

Interventions

temsirolimus 1binimetinib 1Valproic Acid 1Trabectedin 1Specimen Handling 1Sirolimus 1Laser Therapy 1Immunoglobulin G 1Enoxaparin 1Disulfides 1Cetuximab 1Biopsy 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Soft Tissue Neoplasms × Aspirin × Clear all
NCT01965002 2018-05-23

Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Stanford University

Phase NA Terminated
5 enrolled 8 charts

Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡